TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 59 filers reported holding TANGO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $246,802 | -15.9% | 74,338 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $293,635 | -45.5% | 74,338 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $538,951 | +100.4% | 74,338 | 0.0% | 0.01% | +100.0% |
| Q3 2022 | $269,000 | -20.2% | 74,338 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $337,000 | -40.1% | 74,338 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $563,000 | -58.6% | 74,338 | -40.2% | 0.01% | -62.5% |
| Q4 2021 | $1,360,000 | -75.2% | 124,338 | -70.7% | 0.02% | -76.5% |
| Q3 2021 | $5,491,000 | – | 424,638 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |